Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Biosion Inc a global RD stage biotechnology company today announced that it has entered into an exclusive license agreement with Aclaris Therapeutics NASDAQ ACRS for worldwide rights excluding Greater China to BSIB
Ascentage Pharmaa global biopharmaceutical company engaged in discovering developing and commercializing therapies to address global unmet medical needs primarily for malignancies today announced that a New Drug Application NDA for its inhouse develo...
Trogenix Ltd today emerged from stealth mode to unveil its groundbreaking therapeutic platform for treating aggressive cancers Built from inception by BIO Capital which specialises in creating breakthrough therapeutic companies
Bristol Myers Squibbtoday announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has recommended approval of Opdivo nivolumab plus Yervoy ipilimumab
InflaRx NVa biopharmaceutical company pioneering antiinflammatory therapeutics targeting the complement system today announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA
Laboratory products are increasingly being purchased online but expert advice is often lacking The Eppendorf online shop addresses this issue by offering a digital product advisor to help potential customers easily find the optimal solution for their...
Lilly Digital Health and Lilly Centre for Clinical Pharmacology a wholly owned subsidiary of USbased Eli Lilly and Company Lilly today announced the establishment of a SGD million Digital Health Innovation Hub in Singapore to accelerate the research...
Enlivex Therapeutics Ltda clinicalstage macrophage reprogramming immunotherapy company today announced the completion of the dosing and initial followup period for the first patient in its Phase I clinical trial evaluating the safety
Eisai Co Ltdand Biogen Incannounced today a positive opinion has been received from the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA recommending approval of the amyloidbeta A monoclonal antibody lecanemab...
QPS Holdings LLC announced today that their Springfield campus QPS Missouri has launched a new Cell Therapy business unit The units first achievement is the opening of a new Leukopak collection and blood product processing center
